Apyx Medical Corporation filings document regulatory disclosures for a surgical aesthetics medical-device issuer. Recent Form 8-K reports cover results of operations, preliminary revenue releases, FDA 510(k) clearance updates for the AYON Body Contouring System, and exhibits tied to company press releases.
The filing record also includes capital-structure and governance disclosures, including an underwritten common stock offering, amendments to the certificate of incorporation, annual meeting voting results, director elections, auditor ratification, executive compensation advisory votes, and related proxy matters.
Apyx Medical (NASDAQ:APYX) filed a DEF 14A announcing its 2025 Annual Meeting of Stockholders to be held on August 7, 2025. Shareholders will vote on: five key proposals including the election of five directors, ratification of RSM US LLP as auditors, advisory vote on executive compensation, frequency of future say-on-pay votes, and an amendment to delete Article EIGHTH from the Certificate of Incorporation.
The meeting will take place at 9:00 AM EST at Ruskin Moscou Faltischek's offices in Uniondale, NY. The record date for voting eligibility is June 17, 2025. Proxy materials will be distributed to shareholders starting June 27, 2025.